Report Content
Chapter 1 Methodology & Scope
1.1 Industy Coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Intravenous infusion pump industry 3600 synopsis, 2018-2032
2.1.1 Business trends
2.1.2 Product type trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Intravenous Infusion Pump Industry Insights
3.1 Industry landscape
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of chronic conditions
3.2.1.2 Increasing number of people undergoing surgical procedures
3.2.1.3 Surging demand for intravenous infusion pumps in homecare settings to limit hospital expenses
3.2.1.4 Rapidly aging diseased population
3.2.2 Industry pitfalls & challenges
3.2.2.1 Patient safety risks
3.2.2.2 Medication errors while using intravenous infusion pumps
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By application
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Reimbursement scenario
3.7 Technology landscape
3.8 Application potential
3.9 Pricing analysis
3.10 Porter's analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.3.1 B. Braun Melsungen AG
4.3.2 Becton, Dickinson and Company
4.3.3 Baxter International Inc.
4.3.4 Medtronic
4.3.5 Terumo Corporation
4.4 Competitive positioning matrix
4.5 Strategic outlook matrix
4.6 Strategy dashboard
Chapter 5 Intravenous Infusion Pump Market, By Product Type
5.1 Key product type trends
5.2 Volumetric
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Market estimates and forecast, 2018 - 2032 (000 Units)
5.3 Insulin
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Market estimates and forecast, 2018 - 2032 (000 Units)
5.4 Syringe
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Market estimates and forecast, 2018 - 2032 (000 Units)
5.5 Patient-Controlled Analgesia Pump
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5.2 Market estimates and forecast, 2018 - 2032 (000 Units)
5.6 Ambulatory
5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6.2 Market estimates and forecast, 2018 - 2032 (000 Units)
5.7 Others
5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million
5.7.2 Market estimates and forecast, 2018 - 2032 (000 Units)
Chapter 6 Intravenous Infusion Pump Market, By Application
6.1 Key application trends
6.2 Oncology
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Pediatrics/Neonatology
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Analgesia/Pain Management
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Diabetes
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Gastroenterology
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.7 Others
6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Intravenous Infusion Pump Market, By End-use
7.1 Key end-use trends
7.2 Hospital & Clinics
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Homecare
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Ambulatory Surgical Centers
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Others
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Intravenous Infusion Pump Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Poland
8.3.7 Switzerland
8.3.8 The Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Thailand
8.4.8 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Peru
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
Chapter 9 Company Profiles
9.1 Baxter International Inc.
9.2 B. Braun Melsungen AG
9.3 Becton, Dickinson and Company
9.4 IRadimed Corporation
9.5 ICU Medical
9.6 Medtronic
9.7 Shenzhen ENMIND Technology Co., Ltd.
9.8 Micrel Medical Devices SA
9.9 Tandem Diabetes Care, Inc.
9.10 Terumo Corporation
9.11 Moog Inc.
9.12 Fresenius Kabi
9.13 Boston Scientific Corporation
9.14 F. Hoffmann-La Roche Ltd.
